Evaluation of the Condition of Rheumatoid Arthritis After Treatment

Shinshu University

Status and phase: Enrolling; Phase 4

Conditions: Rheumatoid Arthritis

Treatments: Drug: The effectiveness of Xeljanz in rheumatoid arthritis patients

Study type: Interventional

Funder types: Other

Identifiers

NCT02157012

Xeljanz2014

Details and patient eligibility

About

To examine the safety and effectiveness after Xeljanz treatment in rheumatoid arthritis patients

Enrollment: 100 estimated patients

Sex: All

Ages: 20 to 90 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Rheumatoid arthritis

Exclusion criteria

• Other connective tissue disease

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

100 participants in 1 patient group

The condition of rheumatoid arthritis

Experimental group

Treatment:

Drug: The effectiveness of Xeljanz in rheumatoid arthritis patients